These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15257126)

  • 21. Atorvastatin.
    Hyatt PJ
    Br J Hosp Med; 1997 Oct 1-14; 58(7):333-6. PubMed ID: 9509055
    [No Abstract]   [Full Text] [Related]  

  • 22. International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
    Richard Hobbs FD; Gensini G; John Mancini GB; Manolis AJ; Bauer B; Genest J; Feldman RD; Harvey P; Jenssen TG; da Silva PM;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):472-80. PubMed ID: 19407658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous treatment of blood pressure and cholesterol beats the 'SILO' approach in lowering cardiovascular risk: results of the CRUCIAL study.
    Aalbers J
    Cardiovasc J Afr; 2011; 22(2):101. PubMed ID: 21556456
    [No Abstract]   [Full Text] [Related]  

  • 24. Atorvastatin: a new agent for hyperlipidemia.
    Kupecz D
    Nurse Pract; 1997 Nov; 22(11):87-8, 90, 93. PubMed ID: 9403876
    [No Abstract]   [Full Text] [Related]  

  • 25. Reduction in cardiovascular events with atorvastatin in type 2 diabetes.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):9-10. PubMed ID: 16455007
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
    Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
    [No Abstract]   [Full Text] [Related]  

  • 27. [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition].
    MMW Fortschr Med; 2005 Nov; 147(45):54. PubMed ID: 16320655
    [No Abstract]   [Full Text] [Related]  

  • 28. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
    MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254
    [No Abstract]   [Full Text] [Related]  

  • 29. Atorvastatin decreases lipoprotein(a): a meta-analysis of randomized trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Jan; 154(2):183-6. PubMed ID: 21996415
    [No Abstract]   [Full Text] [Related]  

  • 30. Atorvastatin--a new lipid-lowering drug.
    Med Lett Drugs Ther; 1997 Mar; 39(997):29-31. PubMed ID: 9121394
    [No Abstract]   [Full Text] [Related]  

  • 31. A rationale for combination therapy in risk factor management: a mechanistic perspective.
    Mason RP
    Am J Med; 2005 Dec; 118 Suppl 12A():54-61. PubMed ID: 16356809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DUAAL: atorvastatin provided an unexpectedly potent heart benefit in patients with chronic stable angina.
    Cardiovasc J Afr; 2008; 19(3):174. PubMed ID: 18568187
    [No Abstract]   [Full Text] [Related]  

  • 33. Atorvastatin: in the management of hyperlipidaemia.
    Ray SK; Rege NN
    J Postgrad Med; 2000; 46(3):242-3. PubMed ID: 11298482
    [No Abstract]   [Full Text] [Related]  

  • 34. [Atorvastatin . A new generation of hypolipemic agents?].
    Azanza JR; Sádaba B; Quetglas EG
    Rev Med Univ Navarra; 1998; 42(1):51-5. PubMed ID: 10420957
    [No Abstract]   [Full Text] [Related]  

  • 35. Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats.
    Lu JC; Cui W; Zhang HL; Liu F; Han M; Liu DM; Yin HN; Zhang K; Du J
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1110-9. PubMed ID: 19413592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients.
    Martín-Ventura JL; Tuñon J; Duran MC; Blanco-Colio LM; Vivanco F; Egido J
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S189-93. PubMed ID: 17130260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD)--a pilot study.
    Mackie FE; Rosenberg AR; Harmer JA; Kainer G; Celermajer DS
    Acta Paediatr; 2010 Mar; 99(3):457-9. PubMed ID: 20050832
    [No Abstract]   [Full Text] [Related]  

  • 38. [Following the ASCOT Study. A statin for every hypertensive patient?].
    MMW Fortschr Med; 2003 Apr; 145(16):8. PubMed ID: 14606391
    [No Abstract]   [Full Text] [Related]  

  • 39. Lipid-lowering medications: what the new guidelines and data mean to women.
    Schwartz JB
    J Gend Specif Med; 2001; 4(2):9-13. PubMed ID: 11480105
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lowering of cholesterol. What role is played by the choice of statins?].
    März W
    MMW Fortschr Med; 2004 Sep; 146(35-36):55. PubMed ID: 15540544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.